Brandon Allison, Author at ISR Market Research

ISR Market Research positions for next stage of growth following ramarketing acquisition

By Brandon AllisonNews

Specialist pharmaceutical outsourcing research business unveils refreshed brand and website as it builds on its established research offering and looks ahead to the next generation of industry intelligence. ISR Market Research (ISR) has unveiled a refreshed brand identity and website,...

Site networks in Clinical Trials: what sponsors value and where the market is headed

By Brandon AllisonClinical Trials

Site networks are becoming a more established part of clinical trial planning. As sponsors, CROs, and sites look for greater operational efficiency and faster site and patient recruitment, site networks are playing a larger role in how trials are managed....

News: ramarketing acquires US market research firm ISR

By Brandon AllisonNews

Strategic life sciences marketing agency ramarketing has completed the acquisition of ISR Market Research, a specialist agency based in North Carolina’s Research Triangle Park (RTP), one of the largest pharmaceutical and biopharma hubs in North America. The deal strengthens ramarketing’s...

Avoiding the clever trap: is your message getting lost?

By Brandon AllisonCustom Research

When your marketing team gathers in a conference room to brainstorm a new campaign or website launch, it is easy to fall in love with a "clever" hook. You craft a headline that sounds sophisticated, punchy, and modern. Your internal...

Solving the mystery of the ghosted proposal

By Brandon AllisonCustom Research

For Sales Leadership and Executive Management at CROs and CDMOs, there is nothing more frustrating than the "ghosted" proposal. Your team spends weeks coordinating with technical experts, refining budgets, and polishing presentations, only for the process to end in total...

Custom vs. syndicated: the strategic market research framework

By Brandon AllisonCustom Research

In the dynamic, high-stakes world of biopharma, every strategic decision hinges on robust, reliable, and trustworthy data. The difference between success and a costly misstep often comes down to the quality of the market intelligence you’re using. But here’s the...

Market research vs. clinical research: the key differences

By Brandon AllisonCustom Research

Market research and clinical research might seem similar. Both involve collecting data to make informed decisions. However, they serve fundamentally different purposes and are governed by distinct principles. Understanding these differences is crucial, especially in the healthcare and life sciences...

Marketing channels data for pharma service providers

By Brandon AllisonClinical Trials, Manufacturing

Support for marketing at pharma service providers Market research helps service providers to not only create relevant, focused content, but also make sure great content reaches their audiences in the ways they are most likely to engage. This is particularly...

How to gain a competitive edge with custom market research

By Brandon AllisonCustom Research

Custom market research solutions for your business In today's dynamic life science landscape, staying ahead of the curve requires more than just intuition; it demands data-driven decisions powered by insightful market research. You likely understand the significance of market research,...

Using biopharma market research to create high value campaigns

By Brandon AllisonCustom Research, Message Testing

Considerations for biopharma industry marketers Marketing campaigns are important customer-facing tools in the biopharma industry, aimed at a variety of objectives from introducing a company or informing potential customers of a company’s capabilities to educating people on a particular topic....

Gene Therapy CDMO Timelines & Selection Attributes

By Brandon AllisonManufacturing

The Long Road to Approval for Gene Therapies We’ve come a long way from the first gene therapy clinical trial in 1990, but for all the hurdles overcome and advancements made, timelines remain one of the most prominent pain points...

Thought Leadership: Data-driven Insights to Fuel Your Content

By Brandon AllisonCustom Research, Thought Leadership

Our Framework for Thought Leadership We have a rich history in collecting primary market research data in support of our clients’ thought leadership programs. According to a Financial Times Longitude1 study, “credible research” is the feature executives valued most in...

Five Steps to CRO Selection

By Brandon AllisonClinical Trials

Sponsors can facilitate successful CRO partnerships by clearly defining the goals of the clinical trial, choosing an outsourcing model that considers project needs and internal capabilities/resources appropriately, communicating consistently and effectively during the decision-making process, and informing provider selection with...

Biopharma Outsourcing Trends for Sterile Injectable Manufacturing

By Brandon AllisonManufacturing

Evolving Perceptions and Practices in Sterile Injectable Outsourcing Sterile injectable medicines provide significant advantages in terms of rapid and accurate drug delivery. Many newer medications cannot be produced as an oral dosage form for various reasons, making injectable delivery an...

Cell & Gene Therapies Outsourcing Trends

By Brandon AllisonManufacturing

The Growing Cell & Gene Market The outsourced cell and gene manufacturing space has experienced notable expansion and change in recent years. As the advancement of cell and gene therapies continues, drug innovator companies have come to rely heavily on...

Phase II/III Outsourced Spend Across Provider Types

By Brandon AllisonClinical Trials

Industry Standard Research conducted a 2022 survey with outsourcers of Phase II/III clinical development activities to better understand the dynamics in this space. Learning how respondents from sponsor organizations apportion their outsourced work across different provider types was of particular...

Using Customer Ratings to Help You Choose the Best CRO

By Brandon AllisonClinical Trials

Introduction My name is Alena, and I am a Senior Director of Clinical Development at a biopharmaceutical company. My job is to ensure successful execution of clinical studies that meet our company’s goals and take into account the scientific rigor...

Optimize CRO Marketing Strategies with Benchmarking Data

By Brandon AllisonClinical Trials

Introduction My name is Zain, and I am the Director of Marketing at a large CRO. My job is to elevate our brand to increase familiarity and awareness of our varied services among sponsor companies. We want to market our...

How Phase I CROs Can Meet Expectations by Understanding Drug Sponsor Needs

By Brandon AllisonClinical Trials

Introduction My name is Brian and I’m the VP of Clinical Operations at a global CRO. My job is to ensure our clinical operations team is prepared to meet the demands of our clients. I am also part of a...

Phase I Clinical Development and Service Provider Selection

By Brandon AllisonClinical Trials

Introduction My name is Shannon and I’m a VP of R&D at a large pharmaceutical company. My job involves creating a clinical development strategy for the next few years, including managing R&D budgets. Another part of my job is to...

Sponsor Perspectives on Outsourced Clinical Trial Logistics

By Brandon AllisonClinical Trials

ISR consistently seeks to demystify the mystical, and there’s plenty of mystery regarding clinical trial logistics. How do sponsors select a provider? Which activities do they outsource the most? Where are these questions heading? To none other than ISR’s latest...

Five Steps to CDMO Selection

By Brandon AllisonManufacturing

Sponsors will see success in their CDMO partnerships by dedicating time and effort to establish a plan that identifies outsourcing drivers, to select a model that matches company needs and resources, to establish a decision-making process and group, and to...

Highly Potent API Manufacturing

By Brandon AllisonManufacturing

Highly potent API manufacturing is a rapidly growing segment of drug development. Those familiar with HPAPI understand its specialized nature and the strict regulations surrounding it. A complicated and resource-intensive process, sponsors often find themselves in need of knowledgeable outsourcing…

Commercial Bioprocessing Market Outlook

By Brandon AllisonManufacturing

Choosing an outsourcing partner for a commercial bioprocessing endeavor carries a gravitas that those outside that endeavor may not appreciate. Equally significant is the challenge facing CMOs in this space, many of whom are competing against larger, well-known manufacturers with…

Cell & Gene Market Outlook

By Brandon AllisonManufacturing

I bet you can’t say “cell & gene therapies” three times fast. And by the time you do, you’ll have missed another article on your newsfeed discussing their intricacies and the headaches they can cause. Here’s one from Industry Standard…

CTMS Benchmarking & Market Dynamics

By Brandon AllisonClinical Trials, Technology

ISR’s CTMS Benchmarking & Market Dynamics (3rd Ed.) aims to tackle clinical trial management systems (CTMS) by helping providers and sponsors alike better understand current trends surrounding this technology and anticipate future ones. This report is the result of primary…

Six Questions to Ask About Your Market Research

By Brandon AllisonCustom Research

How do you ensure the research products and services you buy will make you confident in the decisions you make? Here are six reasons why Industry Standard Research ensures you are getting the value you should expect from quality market…